−0.27HKD
−193.19 MHKD
681.78 KHKD
553.41 M
About BRII BIOSCIENCES L
Sector
CEO
Zhi Hong
Website
Headquarters
Haidian
Employees (FY)
128
Founded
2017
ISIN
KYG1645A1094
FIGI
BBG011MPQG39
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The firm also focuses on developing therapies for infectious diseases and central nervous system diseases. The company was founded by Zhi Hong on December 8, 2017, and is headquartered in Beijing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2137 is 1.00 HKD — it has increased by 2.04% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange BRII BIOSCIENCES L stocks are traded under the ticker 2137.
BRII BIOSCIENCES L is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
2137 stock is 6.32% volatile and has beta coefficient of 1.41. Check out the list of the most volatile stocks — is BRII BIOSCIENCES L there?
2137 earnings for the last quarter are −0.28 HKD per share, whereas the estimation was −0.53 HKD resulting in a 46.94% surprise. The estimated earnings for the next quarter are −1.16 HKD per share. See more details about BRII BIOSCIENCES L earnings.
Yes, you can track BRII BIOSCIENCES L financials in yearly and quarterly reports right on TradingView.
2137 stock has risen by 13.64% compared to the previous week, the month change is a 1.01% rise, over the last year BRII BIOSCIENCES L has showed a 77.68% decrease.
2137 net income for the last quarter is 16.30 M HKD, while the quarter before that showed −214.79 M HKD of net income which accounts for 107.59% change. Track more BRII BIOSCIENCES L financial stats to get the full picture.
Today BRII BIOSCIENCES L has the market capitalization of 715.05 M, it has increased by 14.77% over the last week.
No, 2137 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2137 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRII BIOSCIENCES L stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 128.00 employees. See our rating of the largest employees — is BRII BIOSCIENCES L on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRII BIOSCIENCES L technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRII BIOSCIENCES L stock shows the sell signal. See more of BRII BIOSCIENCES L technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BRII BIOSCIENCES L future price: according to them, 2137 price has a max estimate of 5.98 HKD and a min estimate of 5.98 HKD. Read a more detailed BRII BIOSCIENCES L forecast: see what analysts think of BRII BIOSCIENCES L and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BRII BIOSCIENCES L EBITDA is −646.32 M HKD, and current EBITDA margin is −94.71 K%. See more stats in BRII BIOSCIENCES L financial statements.